Accueil>>Signaling Pathways>> Microbiology & Virology>> HCV>>HCV-IN-31

HCV-IN-31 (Synonyms: Hepatitis C Virus Inhibitor 31)

Catalog No.GC62138

HCV-IN-31 (composé 4) est un inhibiteur du VHC, avec une CE50/CE95 de 15,7 μM pour le réplicon du VHC.

Products are for research use only. Not for human use. We do not sell to patients.

HCV-IN-31 Chemical Structure

Cas No.: 1998705-62-6

Taille Prix Stock Qté
10mM (in 1mL DMSO)
111,00 $US
En stock
5 mg
101,00 $US
En stock
10 mg
158,00 $US
En stock
25 mg
317,00 $US
En stock
50 mg
504,00 $US
En stock
100 mg
806,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1].

[1]. Jean-Pierre Sommadossi, et al. BETA-D-2-DEOXY-2-ALPHA-FLUORO-2- BETA-C-SUBSTITUTED-2-MODIFIED N6-SUBSTITUTED PURINE NUCLEOTDES FORHCV TREATMENT. US20160257706A1.

Avis

Review for HCV-IN-31

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for HCV-IN-31

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.